| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/06/2002 | CA2434671A1 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 09/06/2002 | CA2434654A1 Antihelminthic drugs as a treatment for hyperproliferative diseases |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2431038A1 6-substituted pyrazolo¬3,4-d|pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 09/06/2002 | CA2426538A1 Tricyclic compounds and their uses |
| 09/05/2002 | US20020123638 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
| 09/05/2002 | US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound |
| 09/05/2002 | US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123532 E.g., bis(3,5-dibromo-2,4,6-trihydroxyphenyl)squaraine and bis(3,5- diiodo-2,4,6-trihydroxyphenyl)squaraine; anticarcinogenic and-tumor agents; fluorescent detector of tumors; sterilization of water; stability; nontoxic |
| 09/05/2002 | US20020123529 Anti-arrhythmia, -ischemic, -proliferative and -diabetic agents; cardiotonic, necrosis; angina pectoris; peripheral and central nervous systems; protecting/preserving organs; inhibition of Na+/H+ exchange; diagnosis hypertonia |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123509 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof |
| 09/05/2002 | US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 09/05/2002 | US20020123505 Stents, catheters, arterio-venous grafts, by-pass grafts and drug delivery ballons with surface coating containing a rapamycin derivative having a tetrazole group |
| 09/05/2002 | US20020123500 CSAIDs.TM block cytokine production; use of a cytokine inhibitor for the treatment of chronic diseases which are caused by inappropriate angiogenesis, such as diabetic retinopathy, tumors, atherosclerosis and arthritis |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123497 For therapy of cancer, neurofibromin benign proliferative disorder; blindness related to retinal vascularization; infections from hepatitis delta and related viruses; prophylaxis of restenosis; polycystic kidney disease |
| 09/05/2002 | US20020123480 Administering 2',5'-oligoadenylate-2',3'-cyclophosphate compound for therapy of disorder of cell proliferation |
| 09/05/2002 | US20020123475 32626, a novel human UDP-glycosyltransferase and uses thereof |
| 09/05/2002 | US20020123469 Antiproliferative colchicine compositions and uses thereof |
| 09/05/2002 | US20020123458 Endostatin protein and fragments thereof |
| 09/05/2002 | US20020123146 Cell culture; for use as tool in gene therapy and cel packaging |
| 09/05/2002 | US20020123139 Antibodies which bind specifically to activin receptor like kinases |
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123081 Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancers |
| 09/05/2002 | US20020123042 Detection of loss of the wild-type hubub1 gene |
| 09/05/2002 | US20020122836 Extract of Arales, Asterales, Coniferales, Equisetales, Euphorbiales, Geraniales, Lamiales, Lillales, Pteridophyta, Ranales, Rhamnales, Rutales, Scrophulariales, Umbellales, or Urticales. |
| 09/05/2002 | US20020122817 Solid instant-release forms of administration and process for producing the same |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122795 Compositions containing gangliosides for use in the treatment of skin disorders |
| 09/05/2002 | US20020122793 Heparinase III and uses thereof |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/05/2002 | DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases |
| 09/05/2002 | DE10107737A1 Verwendung eines Konjugats aus IL-6 und einem IL-6 Rezeptor zur Tumortherapie Use of a conjugate of IL-6 and an IL-6 receptor for tumor therapy |
| 09/05/2002 | DE10107663A1 Testosteronhaltiges transdermales therapeutisches System und Verfahren zu seiner Herstellung Testosterone-containing transdermal therapeutic system and process for its preparation |
| 09/05/2002 | DE10106835A1 Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen Signal transduction 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences |
| 09/05/2002 | DE10106827A1 Verwendung eines Konjugats aus Interleukin-6(IL-6) und seinem Rezeptor zur Induktion der zellulären Expression des Stammzellfaktors (SCF) und von Flat-3-Ligand (Flt-3L) Use of a conjugate of interleukin-6 (IL-6) and its receptor in the induction of cellular expression of the stem cell factor (SCF) and Flat-3 ligand (Flt-3L) |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236799A2 Human nucleic acid sequences derived from breast tumor tissue |
| 09/04/2002 | EP1236477A2 A formative agent of protein complex |
| 09/04/2002 | EP1236474A1 Negative regulation of epidermal growth factor receptor activity by Mig-6 |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1236463A1 Topical cosmetic composition |
| 09/04/2002 | EP1236173A2 Methods and devices for identifying patterns in biological systems |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235924A1 Antisense modulation of rank expression |
| 09/04/2002 | EP1235922A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 09/04/2002 | EP1235912A2 Tumour-specific vector for gene therapy |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235850A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/04/2002 | EP1235848A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 09/04/2002 | EP1235847A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235841A1 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235815A1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235797A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 09/04/2002 | EP1235777A2 Vitamin d analogues |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | EP1235597A2 Nucleic acid delivery system |
| 09/04/2002 | EP1235596A2 Use of lytic toxins and toxin conjugates |
| 09/04/2002 | EP1235595A2 Integrin-mediated drug targeting |
| 09/04/2002 | EP1235590A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 09/04/2002 | EP1235586A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 09/04/2002 | EP1235578A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/04/2002 | EP1235568A2 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 09/04/2002 | EP1157028B1 Novel substituted 11.beta steroid derivatives, method for preparing same and intermediates of said method, use as medicine and compositions containing them |
| 09/04/2002 | EP1056736B1 Alternate method for acylating 10-deacetylbaccatin iii selectively at the c-10 position |
| 09/04/2002 | EP1054886B1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 09/04/2002 | EP1049478B1 Composition containing propargylamine for enhancing cancer therapy |
| 09/04/2002 | EP0969828B1 Butyrate prodrugs derived from lactic acid |
| 09/04/2002 | EP0966476B1 Quinazolinone compounds |
| 09/04/2002 | EP0944629B1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/04/2002 | EP0934278B1 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
| 09/04/2002 | EP0847397B1 water-soluble c-ring analogues of 20 (s)-camptothecin |
| 09/04/2002 | EP0832104B1 Dolastatin derivatives, their preparation and use |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0801571B1 Soluble 2-chloro-2'-deoxyadenosine formulations |